Skip to main navigation Skip to search Skip to main content

Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug─Past and Future

  • Israel Agranat*
  • , Ilaria D’Acquarica*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

The chiral opioid analgesic tramadol was patented (1962) as a cis- and trans-racemates mixture. A first chiral switch led to the (±)-cis-(1RS,2RS) racemate, patented and approved as Tramal (1980), preferred over the (+)-cis-(1R,2R)-enantiomer. Consecutive chiral switches of (±)-cis-tramadol to (+)-cis-(1R,2R)-tramadol/salts were patented. This Viewpoint calls for developing (+)-cis-(1R,2R)-tramadol medicines and recognizing tramadol medicines as potential psychedelics to overcome the spreading tramadol crisis.

Original languageEnglish
Pages (from-to)1409-1416
Number of pages8
JournalACS Medicinal Chemistry Letters
Volume15
Issue number9
DOIs
StatePublished - 12 Sep 2024

Bibliographical note

Publisher Copyright:
© 2024 American Chemical Society.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Analgesics
  • Chiral Switch
  • Opioid Crisis
  • Patents
  • Psychedelic
  • Stereochemistry
  • Tramadol

Fingerprint

Dive into the research topics of 'Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug─Past and Future'. Together they form a unique fingerprint.

Cite this